March 23, 2026 • Week 1
Top items this week
-
AI Safety & Controls:
Major vendors continue to tighten model safety: new guidance around "elevated risk" labels and sandboxed agent execution are being tested by enterprise providers. Projects should review prompt-hardening and provenance checks.
-
Biology — CRISPR Delivery Advances:
Researchers reported incremental improvements in targeted CRISPR delivery vectors that reduce off-target edits in preclinical trials — promising for gene therapy safety.
-
Medicine — mRNA Therapeutics Progress:
mRNA platforms expand beyond vaccines: new phase I studies explore mRNA-encoded monoclonals for infectious disease and rapid-response oncology candidates.
-
Tech — Browser Security Update:
Chrome patches for a CSS rendering zero-day were issued; update browsers and embedded WebViews where applicable.
Actionable: update dependency lists, schedule model-safety reviews, and check site analytics for visitor interest in biotech and AI content.